Director, Oncology Biomarkers & Translational Medicine

Glaxosmithkline

Philadelphia (Philadelphia County)

Hybrid

USD 190,000 - 316,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

GlaxoSmithKline seeks a Director of Oncology Translational Medicine, Clinical Biomarkers, to lead biomarker strategies for late‑stage oncology assets. You will collaborate with senior leaders to align biomarker plans with clinical development, leverage cutting‑edge technologies, and drive decision‑making in drug development.

You will oversee sample testing plans, validate biomarkers, and contribute to regulatory strategies, with a mix of clinical and translational responsibilities across matrix

Qualifications

  • Ph.D. or equivalent with 7+ years or M.Sc. with 10+ years of drug development experience in the pharmaceutical industry, with a solid background in Oncology clinical biomarkers, expertise in late‑phase oncology studies, and translational research within clinical development.

Responsibilities

  • Collaborating closely with the Clinical Biomarker Executive Director to drive the design, alignment, and execution of clinical biomarker and translational medicine strategies focused on identifying predictive biomarkers that enable clinical success.
  • Validating and implementing biomarker strategies, including target engagement, pharmacodynamic, and proof‑of‑mechanism biomarkers, for clinical‑phase programs to support patient stratification, dose selection, and enable clinical go/no‑go decisions.
  • Participating in tumor‑specific Biomarker Matrix teams, with responsibility for executing clinical biomarker strategies for late‑stage oncology programs, while working closely with internal and external stakeholders, as well as disease area strategy teams.
  • Representing Translational Medicine at Clinical Development Matrix Teams (CMT) to establish biomarker‑driven decision‑making criteria and their seamless integration into clinical study designs, aligning with clinical study objectives
  • Supporting disease area strategies and translational objectives by defining biomarker priorities, areas of interest, and generating decision‑enabling evidence packages informed by real‑world datasets, internal and external data and partnerships (For e.g., research collaborations, KEE consultations).
  • Identifying cutting‑edge science and technological advances to incorporate into biomarker strategies for guiding indication selection, patient enrichment, and combination strategies.
  • Overseeing and/or developing sample testing plans and delivering high‑quality biomarker data packages to inform clinical development and regulatory strategies.
  • Managing effective relationships with clinical and scientific operations, diagnostics, medical science, medical affairs, regulatory, portfolio management, and commercial functions.
  • Supporting the expansion of mechanism and disease understanding to generate insights for indication expansion and scientific exchange as needed.
  • Defining and studying mechanisms of resistance to enable reverse translation, inform next‑line strategies, support patient enrichment, and influence life cycle management of assets.
  • Contributing to the company's scientific credibility through publications and presentations.

Skills

Analytical Thinking
Clinical Data Interpretation
Clinical Data Review
Clinical Development
Clinical Trial Designs
Digital Fluency
Drug Regulatory Affairs
Executive Presence
Hematology and Oncology
Matrix Leadership
Real World Evidence
Scientific Presentations

Education

Ph.D. or equivalent doctoral degree

Job description

GlaxoSmithKline seeks a Director of Oncology Translational Medicine, Clinical Biomarkers, to lead biomarker strategies for late‑stage oncology assets. You will collaborate with senior leaders to align biomarker plans with clinical development, leverage cutting‑edge technologies, and drive decision‑making in drug development.

You will oversee sample testing plans, validate biomarkers, and contribute to regulatory strategies, with a mix of clinical and translational responsibilities across matrix

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Director, Oncology Translational Biomarkers
Director, Oncology Translational Biomarkers

Glaxosmithkline • Waltham (MA)

On-site
USD 190,000 - 316,000
Director, Oncology Translational Medicine & Biomarkers
Director, Oncology Translational Medicine & Biomarkers

GSK plc • Pennsylvania

Hybrid
USD 190,000 - 316,000
Health care and other insurance
Retirement benefits
Paid holidays
+2
Director, Oncology Translational Medicine & Biomarkers
Director, Oncology Translational Medicine & Biomarkers

Glaxosmithkline • Collegeville (PA)

On-site
USD 190,000 - 316,000
Health care benefits
Retirement benefits
Paid holidays
+2
Director, Oncology Translational Medicine & Biomarkers
Director, Oncology Translational Medicine & Biomarkers

Glaxosmithkline • Upper Providence

Hybrid
USD 190,000 - 316,000
Director, Early Oncology Translational Biomarkers
Director, Early Oncology Translational Biomarkers

Women In Bio • Waltham (MA)

On-site
USD 190,000 - 316,000
Health insurance
Retirement benefits
Paid holidays
+3
Senior Diagnostics Planning Lead, Oncology Translational Medicine
Senior Diagnostics Planning Lead, Oncology Translational Medicine

Glaxosmithkline • Waltham (MA)

Hybrid
USD 152,000 - 253,000
Director, Precision Oncology Diagnostics
Director, Precision Oncology Diagnostics

1925 GlaxoSmithKline LLC • Upper Providence

Hybrid
USD 190,000 - 316,000
Health care and other insurance
Retirement benefits
Paid holidays
+2
Senior Oncology Diagnostics Planning Lead
Senior Oncology Diagnostics Planning Lead

GlaxoSmithKline plc • Upper Providence

Hybrid
USD 140,000 - 180,000
Director, Precision Diagnostics in Oncology
Director, Precision Diagnostics in Oncology

Glaxosmithkline • Upper Providence

Hybrid
USD 190,000 - 316,000
Annual bonus
Health care and other insurance
Retirement benefits
+3
Director of Translational Oncology & Biomarker Strategy
Director of Translational Oncology & Biomarker Strategy

ALX Oncology • South San Francisco (CA)

Hybrid
USD 240,000 - 260,000
Stock programs
Performance-based bonus
401K